Pat W. Whitworth, MD
Although research findings have established many applications for genetic information in breast cancer, not enough patients are being tested for the risk of germline mutations and new strategies are needed to broaden the clinical application of genomic advancements, according to experts in the field.
Figure. Gene Mutations in a Breast Cancer Population2
Table. Guideline Definition of Patients Testing Positive2
Whitworth, a breast cancer surgeon at Saint Thomas Health in Nashville, Tennessee, is among those advocating for change. The failure to screen sufficiently for potentially deleterious BRCA
mutations stems from systemic problems, Whitworth maintained during a presentation at the 36th Annual
Miami Breast Cancer Conference®
... to read the full story